What we stand for

Fetalix is a biotech company localized in Portugal whose main mission is to solve a huge health problem of a growing ageing society: Low Back Pain.

The vision

We envision a world where age does not stop you - a world free from pain where people can enjoy longer active lives.

Our Journey

2017
Pre-registration
  • Establishment of partnerships with abattoirs

  • Publication of scientific research article (Scientific Reports)
2020
We started
  • Fetalix, Lda registration in Portugal
    Patent submission  (WO2021118379A1)
    EIT Jumpstarter 1st prize in the Health category (European Institute of Innovation & Technology - EIT)
    Publication of scientific article (Trends in Biotechnology)

2021
Recognition
  • Amyris Innovation BIG Impact Award (Universidade Católica Portuguesa and Amyris Inc.)

2022
Product
  • First prototype
    Publication of research article (Biomaterials Advances)

2022
Achievements
  • Women TechEU Grant (European Innovation Ecosystems work programme of Horizon Europe)
    Participation in EIC T2M Business Idea Validation Bootcamp
    Showcase at SIM Conference
    Establishment of collaborations with Católica Porto Business School and Veterinary clinics (One Vet and Clinica Veterinária Montenegro)
    First master student (Leonor Sousa) and trainee (Margarida Rodrigues) joining the team

2024
Achievements
  • First pre-clinical tests in animals
    Winner of Startup Lab competition
    Selection for EIT Health Innostars Competition

2025
Growing
  • ANI certification of R&D
    Talent+ Internships (IEFP)
    Spine Innovation Forum
    FCT PhD Fellowship awarded to Leonor Moura
    Assessment of market potential (survey to dog owners and veterinarians)

2026
Now
  • FET-DISC Project (Awarded by Portugal 2030 SIID - Business R&D Individual Operations)
    EIC Pre-Accelerator
    Joined Portugal Ventures portfolio through Call INNOV-ID
    Patent granted in Europe (WO2021118379A1)
    Hiring of 2 new human resources
    Showcase at SIM Conference
    Participation in BIO-Europe Spring 2026

Next
What’s next
  • Validation in large animal model
    Clinical trials
    Regulatory approval

Resilient minds empowered by purpose

Joana Caldeira, PhD.
Co-Founder and CEO of Fetalix
Development biologist and entrepreneur
Morena Fiordalisi, PhD
Co-Founder and CTO of Fetalix
Medical Biotechnologist and entrepreneur
Raquel Gonçalves, PhD
Co-Founder and COO of Fetalix
Stem cell biologist, regulatory compliance expert
Hugo Prazeres, PhD, MBA
Co-Founder and CMD of Fetalix
Manager and serial entrepreneur

Our Team

Isabel Oliveira, PhD
Applied Scientist
Diana Rodrigues, PhD
Applied Scientist
Leonor Moura
PhD Student
Carolina Amaral
MSc Student
Ana Carolina Monteiro
Project Manager

Advisory Board and Mentors

Mário Barbosa, PhD
Biomaterial Researcher
Paulo Pereira, MD, PhD
Neurosurgeon
Irina Amorim, DVM, PhD
Veterinary doctor
Nuno Neves, MD, PhD
Orthopedic Spine Surgeon
Gianluca Vadalá, MD, PhD
Orthopedic Surgeon
Klaus Sommer (mentor)
Former Head of Business
Management - Bayer

Our trusted partners

The science behind

Evidence-driven innovation

Exclusive source

Our patented solution is derived from bovine fetal tails (livestock waste intended for incineration).

Regenerative & anti-angiogenic properties

Enriched with regenerative and anti-angiogenic properties, it restores biological cues lost with aging, promoting tissue regeneration

Exclusive source

Our patented solution is derived from bovine fetal tails (livestock waste intended for incineration).

Regenerative & anti-angiogenic properties

Enriched with regenerative and anti-angiogenic properties, it restores biological cues lost with aging, promoting tissue regeneration

Take part in the healthcare revolution!
Join our mission to transform spinal health improving the lives of millions of people
Contact us